<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1506222196
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2009
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        SELECTA PLUS 5MG-12.5MG F.C. TABLETS
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        HYDROCHLOROTHIAZIDE,BISOPROLOL FUMARATE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        12.5,5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        do not store above 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        19.55
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Jamjoom Pharmaceuticals Factory Company" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Jamjoom Pharmaceuticals Factory Company
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 394]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            JAMJOOM PHARMACEUTICALS CO. LTD.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Jamjoom Pharmaceuticals Factory  Company
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        C07AB07
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Selecta Plus&trade; contains the active substances bisoprolol and hydrochlorothiazide:<br />&bull; Bisoprolol belongs to a group of medicines called beta-blockers and is used to lower blood pressure.<br />&bull; Hydrochlorothiazide belongs to a group of medicines called thiazide diuretics (&ldquo;water tablets&rdquo;) and also<br />helps to lower blood pressure by increasing urine output.<br />This medicine is used to treat mild to moderate high blood pressure.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not take Selecta Plus&trade;<br />Do not take Selecta Plus&trade; if one of the following conditions applies to you:<br />&bull; Allergy (hypersensitivity) to bisoprolol, hydrochlorothiazide, other thiazides, sulphonamides, or to any<br />of the other ingredients (see section 6 &lsquo;What Selecta Plus&trade; contains&rsquo;),<br />&bull; Severe asthma or certain severe forms of chronic bronchial diseases,<br />&bull; Heart failure not controlled by therapy, or cardigenic shock (an acute serious heart condition causing<br />low blood pressure and circulatory failure),<br />&bull; Certain cardiac rhythm disorders, in particular slow heart rate causing problems, conduction<br />disturbances or a disorder called sick sinus syndrome,<br />&bull; Untreated phaeochromocytoma (tumour of the adrenal gland secreting substances which induce severe<br />high blood pressure),<br />&bull; Severe blood circulation problems in your limbs (such as Raynaud&rsquo;s syndrome which may cause your<br />fingers or toes to tingle or turn pale or blue),<br />&bull; Increased blood acidity (metabolic acidosis) as a result of severe illness,<br />&bull; Severe liver or kidney problems,<br />&bull; Low blood levels of potassium, not responding to treatment,<br />&bull; If you are taking sultopride (which is used to treat certain psychiatric disorders).<br />Take special care with Selecta Plus&trade;<br />Never suddenly stop taking treatment, in particular if you suffer from certain heart disorders (ischaemic<br />heart disease, for example angina pectoris).<br />Tell your doctor before taking Selecta Plus&trade; if any of the following conditions applies to you:<br />&bull; Any heart disease such as heart failure, disturbances in heart rhythm, or Prinzmetal&rsquo;s angina.<br />&bull; Less severe blood circulation problems in your limbs (in particular Raynaud&#39;s syndrome).<br />&bull; Kidney or liver problems. &bull; Phaeochromocytoma (tumour of the adrenal gland).<br />&bull; Less severe chronic bronchial disease (asthma or chronic obstructive airway disease).<br />&bull; diabetes. &bull; thyroid disorders. &bull; psoriasis. &bull; strict fasting.<br />In addition, tell your doctor:<br />&bull; If you have ever suffered from gout, as Selecta Plus&trade; may enhance the risk for gout attacks,<br />&bull; If you are going to have an anaesthetic (e.g. for surgery) because Selecta Plus&trade; may influence how<br />your body reacts to this situation,<br />&bull; If you plan to have desensitisation therapy, because Selecta Plus&trade; may make it more likely that you<br />experience an allergic reaction, or that such a reaction may be more severe,<br />&bull; If you are breast-feeding or intend to do so,<br />&bull; If you intend to expose yourself to the sun or to artificial UV light, as a few patients have experienced<br />skin rash after exposure to sunlight. In this case, you should protect your skin while you are treated with<br />Selecta Plus&trade;.<br />Additional tests<br />Hydrochlorothiazide works by influencing the salt and water balance in your body. Your doctor may<br />want to check this from time to time. This is especially important if you have additional conditions which<br />may become worse if the electrolyte balance is disturbed. Your doctor will also check your levels of<br />blood fats, uric acid, or blood glucose from time to time.<br />This medicine is not recommended at the same time as lithium (used to treat some psychiatric disorders)<br />or medicines used to treat high blood pressure, angina pectoris or irregular heart beat (such as verapamil,<br />diltiazem or bepridil) (see section &ldquo;Taking other medicines&rdquo;).<br />Competitive athletes should be aware that this product contains an active substance that may give a<br />positive reaction in doping tests.<br />Taking other medicines<br />Please tell your doctor or pharmacist if you are taking or have recently taken any other medicine,<br />including medicines obtained without a prescription.<br />You must not take Selecta Plus&trade; if you are treated with the following medicines (see above, Do not take<br />Selecta Plus&trade;):<br />&bull; sultopride, which is used to treat some forms of psychiatric disorders.<br />Take Selecta Plus&trade; with any of the following medicines only if your doctor has advised you to do so, as it<br />is generally not recommended (see above, Take special care with Selecta Plus&trade;):<br />&bull; certain medicines used to treat high blood pressure, angina pectoris or irregular heart beat (such as<br />verapamil or diltiazem or bepridil) which may increase the risk of heart rhythm disorders,<br />&bull; lithium, which is used to treat some forms of psychiatric disorders.<br />Taking Selecta Plus&trade; with food and drink<br />Selecta Plus&trade; may be taken with or without food, but must be taken in the morning. Swallow the tablet<br />with some liquid. Do not chew.<br />Pregnancy and breast-feeding<br />You must tell your doctor if you are pregnant or if you think that you are. Usually, your doctor will<br />advise you to take another medicine instead of Selecta Plus&trade;, as it is not recommended during<br />pregnancy. This is because hydrochlorothiazide crosses the placenta and its use after the third month of<br />pregnancy may cause potentially harmful fetal and neonatal effects.<br />Use of this medicine is not recommended during breast-feeding.<br />Ask your doctor or pharmacist for advice before taking any medicine.<br />Driving and using machines<br />Normally Selecta Plus&trade; does not affect your ability to drive or use machines. However, your individual<br />response may influence your ability to concentrate and react. If this happens, do not drive vehicles or use<br />machines.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take Selecta Plus&trade; exactly as your doctor has told you. You should check with your doctor or<br />pharmacist if you are not sure.<br />Unless otherwise recommended, Take orally 1 film-coated tablet Selecta Plus&trade; (5 mg bisoprolol<br />fumarate and 12.5 mg hydrochlorothiazide) once daily. If the blood pressure is only inadequately reduced<br />the dose may be increased to 2 film-coated tablets (equivalent to 10 mg bisoprolol and 25 mg<br />hydrochlorothiazide) once daily.<br />Children<br />There is no experience with this medicine in children therefore its use cannot be recommended for<br />children.&nbsp;</p><p>If you take more Selecta Plus&trade; than you should<br />If you have taken more Selecta Plus&trade; tablets than you should, inform your doctor immediately.<br />Depending on the degree of overdose, your doctor can decide what measures are necessary.<br />Symptoms of an overdose may include low blood pressure, slow heartbeat, sudden heart problems,<br />dizziness, nausea, sleepiness, sudden breathing problems, low blood sugar.<br />If you forget to take Selecta Plus&trade;<br />If you forget to take this medicine, take it as soon as you remember. Then take your next dose at its<br />usual time. However, if it is almost time for your next dose skip the dose you missed. Do not take a<br />double dose to make up for a forgotten tablet.<br />If you stop taking Selecta Plus&trade;<br />Never stop taking this medicine except on your doctor&#39;s advice. Otherwise your condition could<br />become much worse. If you have to stop treatment, your doctor will usually advise you to reduce the<br />dose gradually.<br />If you have any further questions on the use of this product, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, Selecta Plus&trade; can cause side effects, although not everybody gets them. These<br />side effects are listed below according to how frequently they may occur.<br />Common side effects (affect 1 to 10 users in 100):<br />&bull; Feeling of coldness or numbness in the hands and feet.<br />&bull; Tiredness, dizziness, headache. These symptoms occur mainly at the beginning of treatment. They<br />are generally mild, and usually disappear within 1 to 2 weeks after starting treatment.<br />&bull; Stomach or intestine problems such as nausea, vomiting, diarrhoea or constipation.<br />Uncommon side effects (affect 1 to 10 users in 1,000):<br />&bull; Muscular weakness and cramps, feeling weak.<br />&bull; Slow heart beat, impaired heart rate, worsening of heart failure, drop in blood pressure on standing<br />or sitting up. &bull; Sleep disorders, depression, loss of appetite.<br />&bull; Breathing problems in patients with asthma or chronic bronchial disease.<br />&bull; Increase blood levels of creatinine or urea.<br />&bull; Stomach complaints.<br />- Increased amylase levels (enzymes involved in digestion).<br />- Disturbed balance of fluids and electrolytes.<br />- Increased blood levels of fat, cholesterol, uric acid or sugar, increase urine levels of sugar.<br />Rare side effects (affect 1 to 10 users in 10,000):<br />&bull; Nightmares, hallucinations. &bull; Allergy-type reactions such as itching, sudden flushing of the<br />face or skin rash, also after exposure to sunlight, hives, small purple-red marks on the skin caused by<br />bleeding under the skin (purpura). &bull; Increase in certain liver enzymes, inflammation of the liver,<br />yellow colouring of the skin and eyes (jaundice). &bull; Erection disorders. &bull; Hearing problems.<br />&bull; Allergic runny nose, reduced tear secretion, visual disturbance.<br />- Decrease in the number of white blood cells (leucopenia), or blood platelets (thrombocytopenia).<br />Very rare side effects (affect less than 1 user in 10,000):<br />&bull; Irritation and redness of the eye (conjunctivitis), hair loss.<br />&bull; Onset or worsening of pre-existing scaly skin rash (psoriasis), onset of thick scaly patches<br />(cutaneous lupus erythematosus).</p><p>&bull; Chest pain.</p><p>&bull; Severe reduction in the number of white blood cells (agranulocytosis).<br />- Inflammation of the pancreas.<br />- A condition with too little acid in the blood (metabolic alkalosis).<br />- Allergic (anaphylactic) reactions, severe blistering skin reactions (Lyell syndrome).<br />If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please<br />tell your doctor or pharmacist. To prevent serious reactions, speak to a doctor immediately if a side<br />effect is severe, occurred suddenly or gets worse rapidly.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep out of the reach and sight of children.<br />Do not store above 30 &ordm;C. Store in the original package.<br />Do not use Selecta Plus&trade; after the expiry date which is stated on the carton and blister.<br />Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how<br />to dispose medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Selecta Plus&trade; each tablet contains the active substances: 5 mg of bisoprolol fumarate &amp;<br />12.5 mg of hydrochlorothiazide (HCTZ).<br />The other ingredients are: Colloidal silicone dioxide, crospovidone, dibasic calcium phosphate<br />dihydrate, magnesium stearate, maize starch, microcrystalline cellulose, opadry white, propylene<br />glycol, simethicone and purified water.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                White to off white, round, biconvex film coated tablets, engraved with 'JP85' on one side and
breakline on the other side.
Selecta Plus™ 5 mg / 12.5 mg of bisoprolol / HCTZ tablets are available in a box of 20 film coated
tablets.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Jamjoom Pharmaceuticals Co., Ltd., Jeddah, Saudi Arabia.<br />Tel: +966-12-6081111, Fax: +966-12-6081222. Website: www.jamjoompharma.com<br />To report any side effect(s):<br />&bull; Saudi Arabia:<br />- The National Pharmacovigilance and Drug Safety Centre (NPC)<br />o Fax: +966-11-205-7662<br />o Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.<br />o Toll free phone: 8002490000 o E-mail: npc.drug@sfda.gov.sa o Website: www.sfda.gov.sa/npc<br />&bull; Other GCC States:<br />&minus; Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                02-2013
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p style="text-align:right">سيليكتا بلس&nbsp;يحتوى على المواد الفعالة بايسبرولول فيوماريت و هيدروكلوروثيازيد:&nbsp;</p><p style="text-align:right">&bull; بايسبرولول ينتمى إلى مجموعة من الأدوية تسمى حاصرات بيتا و يستخدم لخفض ضغط الدم المرتفع.<br />&bull; هيدروكلوروثيازيد ينتمى إلى مجموعة من الأدوية تسمى مدرَّات البول الثِّيازيدية &quot;أقراص الماء&quot; و يساعد أيضا فى خفض ضغط<br />الدم عن طريق زيادة كمية البول الخارج من الجسم.<br />هذا الدواء يستخدم لعلاج ضغط الدم المرتفع الخفيف إلى متوسط الحدة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p style="text-align:right">لا تتناول سيليكتا بلس<br />إذا كنت تعانى من إحدى الحالات المرضية الآتية: &trade; لا تتناول سيليكتا بلس<br />&bull; حساسية مفرطة لبايسبرولول ، هيدروكلوروثيازيد أو أى ثيازيد آخر، سلفوناميدات أو أى من المكونات الأخرى لهذا الدواء<br />. (&quot; &trade; ( انظر إلى الجزء رقم ٦ &quot; ما هي مكونات أقراص سيليكتا بلس<br />&bull; ربو حاد أو مرض رئوى مزمن شديد.<br />&bull; قصور فى القلب لم يتم السيطرة عليه عن طريق الأدوية أو الصدمة القلبية (حالة مرضية خطيرة تصيب القلب تسبب انخفاض ضغط<br />الدم و قصور فى الدورة الدموية).<br />&bull; إضطرابات معينة فى إيقاع القلب خاصة انخفاض معدل ضربات القلب، إضطرابات التوصيل فى القلب أو إضطراب يسمى متلازمة<br />العقدة الجيبية المريضة.<br />&bull; مرض القواتم الذى لم تتم معالجته بعد و هو مرض نادر يصيب الغدة الكظرية مما يجعلها تفرز مواد تسبب ارتفاع شديد فى ضغط<br />الدم.<br />&bull; مشكلة حادة فى الدورة الدموية فى الأطراف ( مثل متلازمة رينود ) مما يؤدى إلى الشعور بوخذ فى أصابع يديك و قدميك أو تصبح<br />شاحبة أو زرقاء اللون.<br />&bull; حماض أيضى و هى حالة يزيد فيها تركيز الحمض فى الدم و تننتج عن المرض الشديد.<br />&bull; مشاكل شديدة فى الكبد أو الكلى.<br />&bull; انخفاض مستويات البوتاسيوم فى الدم الذى لا يستجيب للعلاج.<br />&bull; إذا كنت تتناول سولتوبريد و هو دواء يستخدم لعلاج بعض الإضطرابات النفسية المعينة.<br />فى الحالات الآتية: &trade; أعط عناية خاصة عند تناول سيليكتا بلس<br />لا تتوقف أبدا بشكل مفاجىء عن تناول هذا الدواء خاصة إذا كنت تعانى بعض الإضطرابات القلبية (مرض نقص التروية القلبية مثل<br />الذبحة الصدرية).<br />إذا كنت تعانى من إحدى الحالات الآتية: &trade; اخبر طبيبك قبل أن تتناول سيليكتا بلس<br />&bull; أى مرض فى القلب مثل قصور القلب، إضطراب إيقاع القلب أو ذبحة برنزميتال.<br />&bull; مشاكل أقل حدة فى الدورة الدموية الطرفية خاصة متلازمة رينود.<br />&bull; مشاكل فى الكبد أو الكلى. &bull; مرض القواتم و هو مرض نادر يصيب الغدة الكظرية.<br />&bull; مرض رئوى أقل حدة مثل الربو أو مرض الإنسداد الرئوى المزمن.<br />&bull; داء السكرى. &bull; إضطرابات الغدة الدرقية. &bull; الصدفية. &bull; الصيام الشديد.<br />أيضا اخبر طبيبك بالآتى:<br />قد يزيد من خطورة نوبات النقرس لديك. &trade; &bull; إذا ما عانيت من قبل من مرض النقرس لأن سيليكتا بلس<br />قد يؤثر على كيفية تفاعُل جسمك مع هذه الحالة. &trade; &bull; إذا ما كنت سوف تخضع لتخدير ما لإجراء عملية جراحية، ذلك لأن سيليكتا بلس<br />قد يزيد من احتمالية إصابتك برد فعل تحسسى أو قد يزيد من حدة &trade; &bull; إذا كنت تخطط لتناول علاج إزالة التحسس، ذلك لأن سيليكتا بلس<br />الحساسية لديك.<br />&bull; إذا كنتِ مرضعة أو تنوين أن تكونى مرضعة.<br />&bull; إذا كنت تنوى أن تتعرض للشمس أو إلى الأشعة الفوق بنفسجية الصناعية لأن عدد قليل من المرضى عانوا من طفح جلدى بعد<br />.&trade; التعرض للشمس. فى هذه الحالة يجب أن تحمى جلدك أثناء علاجك بسيليكتا بلس<br />فحوصات إضافية:<br />هيدروكلوروثيازيد يعمل عن طريق التأثير على توازن الملح و الماء فى جسمك. قد يريد طبيبك التحقق من ذلك من حين لآخر. و يكون<br />هذا هام بشكل خاص إذا كنت تعانى أيضا من حالات مرضية أخرى و التى قد تزداد سوءا إذا حدث أى إضطراب فى توازن الكهارل<br />(توازن الملح و الماء فى الجسم).<br />سوف يقوم طبيبك أيضا بالتحقق من مستويات الدهون، حمض اليوريك أو السكر فى دمك من حين لآخر.<br />لا ينصح بتناول هذا الدواء فى نفس الوقت مع الليثيوم (دواء يستخدم لعلاج بعض الإضطرابات النفسية) أو مع ڤيراباميل، دلتيازيم أو<br />بيبريديل (أدوية تستخدم لعلاج ارتفاع ضغط الدم، الذبحة الصدرية أو عدم انتظام ضربات القلب)، انظر إلى الجزء بعنوان &quot;تناول<br />أدوية اخرى&quot;.<br />يجب أن يعلم الرياضيون المشاركون فى الأنشطة التنافسية أن هذا الدواء يحتوى على مادة فعالة قد تعطى نتائج إيجابية فى اختبارات<br />الكشف عن المنشطات.<br />تناول أدوية أخرى<br />يرجى إخبار طبيبك أو الصيدلى عن أى أدوية تتناولها حاليا أو تناولتها مؤخرا. هذا يشمل الأدوية التى يمكنك شراؤها بدون وصفة طبية.</p><p style="text-align:right">لا يجب أن تتناول سيليكتا بلس&nbsp;إذا كنت تتناول الأدوية التالية (انظر الجزء بالأعلى بعنوان&quot; لا تتناول سيليكتا بلس &trade; لا يجب أن تتناول سيليكتا بلس<br />&bull; سولتوبريد و هو دواء يستخدم لعلاج بعض الإضطرابات النفسية المعينة.<br />مع أى من الأدوية التالية فقط إذا نصحك طبيبك بذلك لأنه بشكل عام لا يوصى بفعل ذلك (انظر إلى الجزء &trade; تناول سيليكتا بلس<br />فى الحالات الآتية &quot;: &trade; المذكور بالأعلى بعنوان &quot; أعط عناية خاصة عند تناول سيليكتا بلس<br />&bull; بعض الأدوية التى تستخدم لعلاج ضغط الدم المرتفع، الذبحة الصدرية أو عدم انتظام ضربات القلب مثل ڤيراباميل، دلتيازيم أو<br />بيبريديل التى قد تزيد من إضطرابات إيقاع القلب.<br />&bull; الليثيوم وهو دواء يستخدم لعلاج بعض الإضطرابات النفسية.<br />مع الطعام و الشراب &trade; تناول سيليكتا بلس<br />قد يؤخذ مع أو بدون الطعام و لكن يجب تناوله فى الصباح. قم ببلع القرص مع بعض من السائل. لا تقم بمضغه. &trade; سيليكتا بلس<br />الحمل و الرضاعة<br />يجب أن تخبرى طبيبك بأنك حاملاً أو تشكين فى كونك حاملاً. فى العادة، سوف ينصحك طبيبك بأن تتناولى دواء آخر بدلا من<br />لأنه لا يوصى بتناوله أثناء الحمل. ذلك لأن هيدروكلوروثيازيد يعبر المشيمة و إستخدامه بعد الشهر الثالث من الحمل قد &trade; سيليكتا بلس<br />يسبب تأثيرات ضارة على الجنين و المواليد.<br />لا يوصى بإستخدام هذا الدواء أثناء الرضاعة. استشر الطبيب أو الصيدلى قبل تناول أى دواء.<br />قيادة المركبات و تشغيل الآلات<br />عادة لا يؤثر هذا الدواء فى قدرتك على القيادة أو تشغيل الآلات. لكن استجابتك الفردية قد تؤثر فى قدرتك على التركيز و التفاعل. إذا<br />حدث هذا، لا تقد المركبات أو تستخدم الآلات.</p><p style="text-align:right">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p style="text-align:right">قم دائما بتناول سيليكتا بلس&nbsp;كما أخبرك طبيبك تماماً. استشر طبيبك أو الصيدلى إذا كنت غير متأكد من طريقة الإستخدام. &trade; قم دائما بتناول سيليكتا بلس<br />المغلفة ( ٥ ملجم بايسوبرولول فيوماريت و &trade; مالم يوصى بغير ذلك يتم تناول قرص واحد بالفم يومياً من أقراص سيليكتا بلس<br />۱۲,٥ ملجم هيدروكلوروثيازيد) إذا لم يتم خفض ضغط الدم بشكل كاف يمكن زيادة الجرعة إلى قرصين ( ما يعادل ۱۰ ملجم<br />بايسوبرولول و ۲٥ ملجم هيدروكلوروثيازيد) مرة واحدة يومياً.</p><p style="text-align:right">الأطفال<br />لم يتم اختبار إستخدام هذا الدواء فى الأطفال لذلك لا يوصى بإستخدام هذا الدواء للأطفال.<br />أكثر مما ينبغى: &trade; إذا كنت تناولت سيليكتا بلس<br />أكثر مما ينبغى يجب أن تخبر طبيبك على الفور. بناءا على درجة الزيادة فى الجرعة، سوف يقرر &trade; إذا تناولت أقراص سيليكتا بلس<br />طبيبك ما هى التدابير اللازمة. أعراض الجرعة الزائدة تشمل انخفاض ضغط الدم، تباطؤ معدل ضربات القلب، مشاكل القلب المفاجئة،<br />دوار، غثيان، نعاس، مشاكل التنفس المفاجئة، انخفاض مستوى السكر فى الدم.<br />:&trade; إذا نسيت أن تتناول سيليكتا بلس<br />إذا نسيت أن تتناول هذا الدواء، قم بتناوله بمجرد تذكرك. ثم خذ الجرعة التالية فى موعدها المعتاد. لكن إذا كان الوقت قد حان لتناول<br />الجرعة التالية لا تتناول الجرعة المنسية. لا تتناول جرعة مضاعفة لتعويض الجرعة المنسية.&nbsp;</p><p style="text-align:right">إذا توقفت عن تناول سيليكتا بلس<br />لا تتوقف أبدا عن تناول هذا الدواء إلا إذا نصحك طبيبك بهذا. و إلا سوف تزداد حالتك سوءا. إذا وجب عليك أن توقف إستخدام هذا<br />الدواء سوف ينصحك طبيبك بتقليل الجرعة تدريجيا.<br />إذا كانت لديك أى أسئلة أخرى عن هذا الدواء، اسأل الطبيب أو الصيدلى.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p style="text-align:right">كما هو الحال مع جميع الأدوية، من المحتمل ظهور أعراض جانبية لسيليكتا بلس<br />الأعراض الجانبية مذكورة بالأسفل طبقا لمدى تكرار حدوثها:<br />أعراض جانبية شائعة ( تصيب ۱ إلى ۱۰ أشخاص من كل ۱۰۰ شخص يستخدم هذا الدواء)<br />&bull; الشعور بالبرودة أو التنميل فى اليدين و القدمين.<br />&bull; الإرهاق، الدوار، الصداع. هذه الأعراض تحدث بشكل رئيسى عند بداية العلاج.<br />عادة ما تكون هذه الأعراض خفيفة و تختفى خلال أسبوع أو اثنين بعد بداية العلاج.<br />&bull; مشاكل فى المعدة أو الأمعاء مثل الغثيان، القىء، الإسهال أو الإمساك.<br />أعراض جانبية غير شائعة ( تصيب ۱ إلى ۱۰ أشخاص من كل ۱۰۰۰ شخص يستخدم هذا الدواء)<br />&bull; ضعف العضلات ، تشنج العضلات و الشعور بالضعف.<br />&bull; تباطؤ ضربات القلب، إضطراب معدل ضربات القلب، ازدياد سوء قصور القلب، انخفاض ضغط الدم عند الوقوف أو الجلوس.<br />&bull; إضطرابات النوم، إكتئاب، فقدان الشهيه.<br />&bull; مشاكل التنفس فى الأشخاص المصابون بالربو أو بمرض رئوى مزمن.<br />&bull; زيادة مستويات الكرياتينين أو اليوريا فى الدم. &bull; مشاكل فى المعدة.<br />&bull; زيادة مستويات الأميليز (انزيم يشارك فى عملية الهضم). &bull; إضطراب فى توازن الكهارل و السوائل.<br />&bull; زيادة مستويات الدهون، الكولستيرول، حمض اليوريا و السكر فى الدم و زيادة مستويات السكر فى البول.<br />أعراض جانبية نادرة ( تصيب ۱ إلى ۱۰ أشخاص من كل ۱۰,۰۰۰ شخص يستخدم هذا الدواء)<br />&bull; الكوابيس و الهلوسة.<br />&bull; حساسية مثل الحكة، إحمرار مفاجىء فى الوجه أو طفح جلدى مفاجىء، أيضا بعد التعرض للشمس حدوث طفح جلدى، علامات<br />صغيرة أرجوانية إلى حمراء اللون تظهر على الجلد ناتجة عن النزف تحت الجلد (فرفرية).<br />&bull; زيادة فى بعض انزيمات الكبد، التهاب الكبد، إصفرار الجلد و العينين (اليرقان).</p><p style="text-align:right">&bull; ضعف الإنتصاب. &bull; مشاكل فى السمع.<br />&bull; سيلان الأنف التحسسى، انخفاض إفراز الدموع، إضطرابات بصرية.<br />&bull; إنخفاض عدد خلايا الدم البيضاء (نقص الكريات البيض) أو نقص الصفائح الدموية (نقص الصفيحات).<br />أعراض جانبية نادرة جدا ( تصيب أقل من ۱ من كل ۱۰۰۰۰ شخص يستخدم هذا الدواء)<br />&bull; إحمرار و تهيج العينين (التهاب الملتحمة) و فقدان الشعر.<br />&bull; بداية ظهور طفح جلدى مصاحب بوجود قشور (الصدفية) أو تفاقم حالته إذا كان موجودا بالفعل و بداية ظهور بقع جلدية متقشرة<br />سميكة (الذئبة الحمامية الجلدية).<br />&bull; ألم فى الصدر. &bull; إنخفاض شديد فى أعداد كرات الدم البيضاء (ندرة المحببات).<br />&bull; التهاب الكبد. &bull; حالة تكون فيها الأحماض قليلة جداً فى الدم (القلاء الأيضى).<br />&bull; حساسية شديدة، تقرح شديد فى الجلد (متلازمة لييل).<br />إذا وصلت أحد الآثار الجانبية لهذا الدواء لمرحلة الخطر أو ظهرت آثار جانبية جديدة لم تذكر في هذه النشرة يرجى اخبار الطبيب أو<br />الصيدلي. لمنع حدوث آثار جانبية خطيرة ، تحدث إلى طبيبك على الفور إذا كان العرض الجانبى خطير، حدث بصورة مفاجئة أو<br />تفاقم بشكل سريع.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p style="text-align:right">يحفظ بعيداً عن متناول و مرأى الأطفال.<br />م. يحفظ داخل العلبة الأصلية. &ordm; يحفظ فى درجة حرارة لا تزيد على ۳۰<br />بعد انتهاء فترة صلاحيتها المكتوب على العلبة. &trade; لا تتناول أقراص سيليكتا بلس<br />اسأل الصيدلي عن طريقة التخلص من الأدوية التي لم تعد بحاجة إليها. لا ينبغي التخلص من الأدوية عبر إلقائها فى بالوعات<br />الصرف أو فى مخلفات المنزل . ستساعد هذه التدابير في حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p style="text-align:right">كل قرص من سيليكتا بلس يحتوى على المواد الفعالة: ٥ ملجم من بايسبرولول فيوماريت و ۱۲٫٥ ملجم هيدروكلوروثيازيد.</p><p style="text-align:right">المواد الأخرى هى: ثانى أكسيد السيليكون الغروى، كروسبوڤيدون، ثنائي القاعدة فوسفات الكالسيوم ثنائي الهيدرات، ستيرات<br />الماغنسيوم، نشا الذرة، سيليلوز دقيق التبلور،أوبادرى أبيض اللون، بروبيلين جليكول، سيميثيكون و ماء منقى.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p style="text-align:right">أقراص سيليكتا بلس&nbsp;بيضاء إلى مائلة للأبيض، دائرية، محدبة الوجهين، مغلفة،&nbsp;محفور علي جانب واحد `JP85` علي الجانب الاخر خط للكسر.</p><p style="text-align:right">أقراص سيليكتا بلس&nbsp;متوفرة فى علبة تحتوى على ۲۰ قرص مغلف.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p style="text-align:right">اسم وعنوان مالك رخصة التسويق و المصنع:<br />شركة مصنع جمجوم للأدوية المحدودة، جدة، المملكة العربية السعودية<br />+۹٦٦-۱۲- ۹٦٦ + فاكس: ٦۰۸۱۲۲۲ -۱۲- الهاتف: ٦۰۸۱۱۱۱<br />www.jamjoompharma.com : الموقع الإلكتروني</p><p style="text-align:right">للإبلاغ عن أي أثار جانبيه:<br />&bull; المملكة العربية السعودية:<br />- المركز الوطني للتيقظ و السلامة الدوائية<br />+۹٦٦-۱۱-۲۰٥- فاكس: ۷٦٦۲ o<br />للإتصال بالإدارة التنفيذية للتيقظ وإدارة الأزمات. o<br />۲۳٤۰-۲۳۳٤-۲۳٥٤-۲۳٥۳-۲۳٥٦- ۹٦٦ +. تحويلة: ۲۳۱۷ -۱۱- هاتف: ۲۰۳۸۲۲۲۲<br />الهاتف المجاني: ۸۰۰۲٤۹۰۰۰۰ o<br />npc.drug@sfda.gov.sa : بريد إلكتروني o<br />www.sfda.gov.sa/npc : الموقع الالكتروني o<br />&bull; دول الخليج الأخرى:<br />- الرجاء الاتصال بالمؤسسات و الهيئات الوطنية في كل دولة</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            02-2013
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Selecta Plus Tablets 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each tablet contains 5 mg bisoprolol fumarate and 12.5 mg hydrochlorothiazide
For the full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Film-Coated Tablets
White to off-white, about 8.0 mm, round biconvex film coated tablets, engraved with 'JP85'
on one side and having break line on the other side.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Mild to moderate essential hypertension.<br />(for additional information see section 5.1).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Other strengths of this medicinal product or other products are available. The usual starting dose<br />is one bisoprolol 5 mg / hydrochlorothiazide 12.5 mg tablet once daily. If the antihypertensive<br />effect of this dosage is inadequate, the dose will be increased to one bisoprolol 5 mg /<br />hydrochlorothiazide 12.5 mg tablet once daily and, if response is still inadequate, to one<br />bisoprolol 10 mg / hydrochlorothiazide 12.5 mg tablet once daily.<br />If discontinuation is necessary, gradual discontinuation of bisoprolol treatment is recommended,<br />since abrupt withdrawal of bisoprolol may lead to an acute deterioration of the patient&#39;s condition,<br />in particular in patients with ischaemic heart disease.<br />The tablets should be swallowed in the morning, and can be taken with food. They should be<br />swallowed with some liquid and not be chewed. Renal and hepatic impairment&nbsp;No dose adjustment is necessary in patients with mild to moderate hepatic impairment or mild to moderate<br />renal impairment (creatinine clearance &gt; 30 ml/min).<br />Elderly patients<br />No dose adjustment is normally required (see section 4.4).<br />Paediatric patients<br />There is no paediatric experience with bisoprolol/hydrochlorothiazide, therefore its use cannot be<br />recommended for children.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                This medicinal product is contraindicated in patients with hypersensitivity to bisoprolol,
hydrochlorothiazide, other thiazides, sulphonamides or any of the
excipients (see section 6.1).
Bisoprolol/HCTZ is contra-indicated in patients with:
- hypersensitivity to bisoprolol, hydrochlorothiazide, other thiazides,
sulphonamides, or any of the excipients
• acute heart failure or during episodes of heart failure decompensation requiring
intravenous inotropic therapy
• cardiogenic shock
• second or third degree AV block
• sick sinus syndrome
• sinoatrial block
• symptomatic bradycardia
• severe bronchial asthma or severe chronic obstructive pulmonary disease
• severe forms of peripheral arterial occlusive disease or severe forms of
Raynaud's syndrome
• untreated phaeochromocytoma
• severe renal impairment (creatinine clearance 30 ml/min)
• severe hepatic impairment
• metabolic acidosis
• refractory hypokalaemia
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Warnings<br />Treatment with bisoprolol must not be withdrawn abruptly unless clearly indicated, since abrupt<br />withdrawal of bisoprolol may lead to an acute deterioration of the patient&#39;s condition in particular<br />in patients with is chaemic heart disease.<br />Bisoprolol must be used with caution in patients with<br />Liver disease<br />Liver disease, thiazide diuretics and related products may trigger hepatic encephalopathy. Should<br />this happen, diuretic therapy must be stopped immediately.<br />Lactating women<br />This medicinal product should not be taken by lactating women.<br />Asthma and chronic obstructive pulmonary disease<br />Beta-blockers may be used only in mild forms of asthma or COPD, using a beta1-selective<br />adrenoceptor blocking agent and a low starting dose. Pulmonary function testing is<br />recommended before the start of therapy. Concomitant broncho dilating therapy is recommended<br />in symptomatic patients. Occasionally, an increase in airway resistance may occur in patients<br />with asthma or COPD, therefore the dose of beta2-<br />stimulants may have to be increased.<br />Cardiac failure&nbsp;</p><p>Patients with compensated cardiac failure who require beta-blocker therapy may be administered<br />bisoprolol using a very low starting dose, to be increased gradually with close medical<br />monitoring.<br />First degree atrioventricular block<br />Having negative dromotropic activity, beta-blockers should be used cautiously in patients with<br />first degree atrioventricular block.<br />Prinzmetal&rsquo;s angina<br />Beta-blockers may increase the frequency and length of vasospastic episodes inpatient with<br />Prinzmetal&rsquo;s angina. A beta1-selective beta-blocker may be used in minoror mixed clinical<br />presentations of Prinzmetal&rsquo;s angina if a vasodilator is used concurrently.</p><p>Peripheral arterial occlusive disease<br />Beta-blockers may aggravate symptoms of peripheral arterial occlusive disease(PAOD) or<br />Raynaud&#39;s syndrome. Such patients should preferably be prescribed abeta1-selective betablocker.<br />Phaeochromocytoma<br />In patients with phaeochromocytoma, bisoprolol/hydrochlorothiazide must not be administered<br />until after alpha-receptor blockade.Blood pressure should be closely monitored.<br />Elderly<br />No dose adjustment is normally required. However, elderly patients should be closely monitored<br />(see paragraph &#39;Fluid and electrolyte balance&#39;).</p><p>Diabetics<br />Diabetic patients should be aware of the risk of hypoglycaemic episodes and of the increased<br />need for careful home glucose monitoringin the initial phase of therapy.The warning signs of<br />hypoglycaemia, particularly tachycardia, palpitations and sweating, may be masked.<br />Psoriasis<br />There have been reports of beta-blockers being associated with worsening of psoriasis, thus<br />patients with psoriasis should receive bisoprolol only if clearly needed.<br />Hypersensitivity reactions<br />In patients at risk of severe anaphylactic reaction to whatever allergen, particularly when using<br />iodine-containing contrast materials (see section 4.5) or during specific immunotherapy<br />(desensitisation), beta-blockers may aggravate the anaphylactic reaction and cause<br />unresponsiveness to the usual doses of epinephrine used to treat hypersensitivity reactions.</p><p>General anaesthesia<br />In patients undergoing general anaesthesia, beta-blockade reduces the incidence of arrhythmias<br />and myocardial ischaemia during induction and intubation, and in the post-operative period. It is<br />currently recommended that maintenance beta-blockade be continued peri-operatively. The<br />anaesthetist must be aware of beta-blockade because of the potential for interactions with other<br />agents, resulting in bradyarrhythmias,attenuation of reflex tachycardia and decreased reflex<br />ability to compensate for bloodloss. If it is thought necessary to withdraw beta-blocker therapy<br />before surgery, this should be done gradually and completed about 48 hours before anaesthesia.<br />Thyrotoxicosis<br />Beta-blockers may mask the cardiovascular signs of hyperthyroidism.</p><p>Competitive athletes<br />Competitive athletes should be aware that this medicinal product contains an agent that may give<br />a positive reaction in doping tests.<br />Strict fasting<br />This medicinal product must be used with caution in patients under strict fasting.<br />Combination with verapamil, diltiazem or bepridil Such combinations require a close clinical<br />and electrocardiographical monitoring, notably in the elderly and at the beginning of the<br />treatment.<br />Fluid and electrolyte balance<br />During long-term therapy with bisoprolol/hydrochlorothiazide, periodic monitoring of serum<br />electrolytes (especially potassium, sodium, calcium), creatinine and urea,serum lipids<br />(cholesterol and triglycerides), uric acid as well as blood glucose is recommended.Long-term,<br />continuous administration of hydrochlorothiazide may lead to fluid andelectrolyte disturbances,<br />in particular hypokalaemia and hyponatraemia, also to hypomagnesaemia and hypochloraemia,<br />and hypercalcaemia.</p><p>Plasma sodium<br />Plasma sodium should be determined before and periodically during therapy. Any diuretic<br />therapy may give rise to hyponatraemia, with serious consequences in some cases.<br />As hyponatraemia may initially be asymptomatic, periodic monitoring is indispensable and<br />should be more frequent in high-risk populations, i.e. the elderly and patients with cirrhosis of<br />the liver.<br />Plasma potassium<br />Potassium loss resulting in hypokalaemia is the greatest risk associated with thiazide<br />diuretics and related drugs. The risk of hypokalaemia (&lt; 3.5 mmol/L) should be anticipated in<br />certain high-risk populations, i.e. the elderly and/or malnourished and/or taking multiple drugs,<br />and patients with coronary artery disease or heart failure, where hypokalaemia increasesthe<br />cardiotoxicity of digitalis glycosides and the risk of cardiac arrhythmia.<br />Also at risk are patients with long QT syndrome, either congenital or iatrogenic.Hypokalaemia<br />(as well as bradycardia) facilitates the development of severe arrhythmias, particularly torsades<br />de pointes, which may be fatal.More frequent plasma potassium monitoring is indicated in all of<br />the above populations, starting within the week after initiation of therapy.</p><p>Plasma calcium<br />Thiazide diuretics and related drugs may reduce urinary calcium excretion, resulting in mild,<br />transient hypercalcaemia. Significant hypercalcaemia may be related to undiagnosed<br />hyperparathyroidism. Therapy must be interrupted before perform in parathyroid function tests.</p><p>Combination with lithium<br />Due to the diuretic, this combination should be avoided.<br />Blood glucose<br />In diabetics, blood glucose must be monitored, especially in the presence of hypokalaemia.<br />Uric acid<br />In patients with hyperuricaemia, the risk for attacks of gout may be increased. Dosage should be<br />adjusted as a function of uric acid plasma concentrations.<br />Kidney function and diuretics<br />Full benefit from thiazide diuretics can be derived only if kidney function is normal or almost<br />normal (serum creatinine levels &lt; 25 mg/L, or 220 &mu;mol/L in adults). Serum creatinine needs to<br />be corrected for age, weight and gender, using Cock roft&rsquo;s<br />formula, for instance:<br />* ClCr = (140 &ndash; age) x weight/0.814 x serum creatinine. Where age is indicated in years, weight<br />in kg, and serum creatinine in micromol/L. The above formula gives ClCr for elderly male<br />subjects, and needs to be corrected for elderly female subjects by multiplying by 0.85.<br />Hypovolaemia secondary to diuretic-induced water and sodium loss at the start of therapy<br />reduces glomerular filtration, which may result in blood urea nitrogen and serum creatinine<br />increases.<br />This transient functional renal impairment is non-relevant in patients with normal kidney<br />function but may worsen pre-existing renal insufficiency.<br />Combination with other antihypertensive drugs<br />It is advisable to reduce the dosage when this medicinal product is combined with another<br />antihypertensive, at least in the initial phase of therapy.<br />Photosensitivity<br />If photosensitivity reactions occur, it is recommended to protect exposed areas to the sun or to<br />artificial UVA light. In severe cases it may be necessary to stop the treatment.<br />Competitive athletes<br />Competitive athletes should be aware that this medicinal product contains an agent that may give<br />a positive reaction in doping tests.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Combinations not recommended<br />Lithium: Bisoprolol / hydrochlorothiazide may intensify the cardiotoxic and neurotoxic effect of<br />lithium through a reduction of lithium excretion. Calcium antagonists of the verapamil type and<br />the diltiazem type: Negative effect on contractility and atrio-ventricular conduction. Intravenous<br />administration of verapamil in patients on &szlig;-blocker treatment may lead to profound hypotension<br />and atrioventricular block. Centrally-acting antihypertensive agents: Concomitant use of<br />centrally-acting antihypertensive agents may lead to a further reduction in heart rate and<br />cardiac output and to vasodilatation. Abrupt withdrawal, may increase the risk of<br />&#39;rebound hypertension&#39;.<br />Combinations to be used with caution<br />Calcium antagonists of the dihydropyridine type: Concomitant use may increase the risk of<br />hypotension, and an increase in the risk of a further deterioration of the ventricular pump<br />function in patients with heart failure cannot be excluded. Concomitant use with other<br />antihypertensive agents or with other medicinal products<br />with blood pressure lowering potential may increase the risk of hypotension.ACE inhibitors,<br />Angiotensin II antagonists: Risk of significant fall in blood pressure and/or acute renal failure<br />during initiation of ACE inhibitor therapy in patients with preexisting sodium depletion<br />(particularly in patients with renal artery stenosis).If prior diuretic therapy has produced sodium<br />depletion, either stop the diuretic 3 days before starting ACE inhibitor therapy, or initiate ACE<br />inhibitor therapy at a low dose. Class-I antiarrhythmic agents: Effect on atrio-ventricular<br />conduction time may be potentiated and negative inotropic effect increased. Class-III<br />antiarrhythmic agents: Effect on atrio-ventricular conduction time may be potentiated.<br />Antiarrhythmic agents that may induce torsade de pointes: Hypokalaemia may facilitate the<br />occurrence of torsades de pointes. Nonantiarrhythmic agents that may induce torsade de pointes:<br />Hypokalaemia may facilitate the occurrence of torsades de pointes.<br />Parasympathomimetic agents: Concomitant use may increase atrio-ventricularconduction time<br />and the risk of bradycardia. Topical beta-blockers (e.g. eye drops for glaucoma treatment) may<br />add to the systemic effects of bisoprolol. Insulin and oral antidiabetic agents: Increase of blood<br />sugar lowering effect. Blockade of beta-adrenoceptors may mask symptoms of hypoglycaemia.<br />Anaesthetic agents: Attenuation of the reflex tachycardia and increase of the risk of hypotension.<br />Digitalis glycosides: Increase of atrio-ventricular conduction time, reduction in heartrate. If<br />hypokalaemia and/or hypomagnesaemia develop during treatment with Bisoprolol /&nbsp;hydrochlorothiazide the myocardium may show increased sensitivity tocardiac glycosides,<br />leading to an enhanced effect and adverse effects of the<br />glycosides. Non-steroidal anti-inflammatory drugs (NSAIDs): NSAIDs may reduce the<br />hypotensive effect. In patients developing hypovolaemia the concomitant administration of<br />NSAIDs can trigger acute renal failure. Beta-sympathomimetics: Combination with bisoprolol<br />may reduce the effect of both agents. Sympathomimetics that activate both beta- and alphaadrenoceptors:<br />Combination with bisoprolol may lead to blood pressure increase. Such<br />interactions are considered to be more likely with nonselective beta-blockers. Potassium-wasting<br />medicinal products may result in increased potassium losses.<br />Methyldopa: haemolysis due to the formation of antibodies to hydrochlorothiazide has been<br />described in isolated cases. The effect of uric-acid-lowering agents may be attenuated in<br />concomitant<br />administration of Bisoprolol / hydrochlorothiazide<br />Cholestyramine, colestipol: reduces the absorption of the hydrochlorothiazide<br />component of Bisoprolol / hydrochlorothiazide.<br />Combinations to be considered<br />Mefloquine: increased risk of bradycardia.<br />Corticosteroids: Reduced antihypertensive effect.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy Category C<br />Bisoprolol<br />Bisoprolol has pharmacological effects that may cause harmful effects on pregnancy and/or the<br />foetus/newborn. In general, beta-adrenoceptor blockers reduce placental perfusion, which has<br />been associated with growth retardation, intrauterine death,abortion or early labour. Adverse<br />effects (e.g. hypoglycaemia and bradycardia) mayoccur in the foetus and newborn infant. If<br />treatment with beta-adrenoceptor blockers is necessary, beta1-selective adrenoceptor blockers<br />are preferable.</p><p>Hydrochlorothiazide:<br />There is limited experience with hydrochlorothiazide during pregnancy, especially during the<br />first trimester. Animal studies are insufficient .Hydrochlorothiazide crosses the placenta. Based<br />on the pharmacological mechanism of action of hydrochlorothiazide its use during the second<br />and third trimester may compromise feto-placental perfusion and may cause fetal and neonatal<br />effects like icterus, disturbance of electrolyte balance and thrombocytopenia.<br />Hydrochlorothiazide should not be used for gestational oedema, gestational hypertension or preeclampsia<br />due to the risk of decreased plasma volume and placental hypoperfusion, without a<br />beneficial effect on the course of the disease.Hydrochlorothiazide should not be used for<br />essential hypertension in pregnant women except in rare situations where no other treatment<br />could be used. Lactation Bisoprolol is not recommended in breastfeeding women.<br />Hydrochlorothiazide can inhibit the milk production.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In general Bisoprolol has no or neglible influence on the ability to drive and use machines.<br />Depending on the individual patient&rsquo;s response to treatment with bisoprolol/hydrochlorothiazide<br />the ability to drive and use machines may be impaired. This should be considered particularly at<br />the start of treatment as well as in conjuction with alcohol.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Common (&ge;1/100 to &lt;1/10), uncommon (&ge;1/1,000 to &lt;1/100), rare (&ge;1/10,000 to &lt;1/1,000), very<br />rare (&lt;1/10,000), not known (cannot be estimated from the available data)<br />Blood and lymphatic system disorders<br />Rare: leucopenia, thrombocytopenia<br />Very rare: agranulocytosis<br />Metabolism and nutrition disorders<br />Uncommon: loss of appetite, hyperglycaemia, hyperuricaemia, disturbances of fluid and<br />electrolyte balance (in particular hypokalaemia and hyponatraemia, also hypomagnesaemia and<br />hypochloraemia as well as hypercalcaemia) Very rare: metabolic alkalosis</p><p>Psychiatric disorders<br />Uncommon: depression, sleep disorders<br />Rare: nightmares, hallucinations<br />Nervous system disorders<br />Common dizziness*, headache*<br />Eye disorders<br />Rare: reduced tear flow (to be taken into consideration in patients wearing contact lenses), visual<br />disturbances<br />Very rare: conjunctivitis<br />Ear and labyrinth disorders<br />Rare: hearing disorders<br />Cardiac disorders<br />Uncommon: bradycardia, atrioventricular conduction disturbances, worsening of<br />pre-existing heart failure&nbsp;</p><p>Vascular disorders<br />Common: feeling of coldness or numbness in extremities<br />Uncommon: orthostatic hypotension<br />Respiratory, thoracic and mediastinal disorders<br />Uncommon: bronchospasm in patients with bronchial asthma or history of<br />obstructive airways disease<br />Rare: allergic rhinitis<br />Gastrointestinal disorders<br />Common: gastrointestinal complaints such as nausea, vomiting, diarrhoea,<br />constipation<br />Uncommon: abdominal complaints<br />Very rare: pancreatitis<br />Hepatobiliary disorders<br />Rare: hepatitis, jaundice&nbsp;</p><p>Skin and subcutaneous tissue disorders<br />Rare: hypersensitivity reactions such as itching, flush, rash, photodermatitis, purpura, urticaria.<br />Very rare: anaphylactic reactions, toxic epidermic necrolysis (Lyell syndrome), alopecia,<br />cutaneous lupus erythematosus. Beta-blockers may provoke or worsen psoriasis or induce<br />psoriasis-like rash.<br />Musculoskeletal and connective tissue disorders<br />Uncommon: muscle weakness, muscle cramps<br />Reproductive system and breast disorders<br />Rare: potency disorders<br />General disorders<br />Common: fatigue*<br />Uncommon: asthenia<br />Very rare: chest pain<br />Investigations<br />Uncommon: increase in amylase, reversible increase of serum creatinine and urea,<br />increased triglyceride and cholesterol levels, glucosuria,<br />Rare: increase in liver enzymes (ASAT, ALAT)<br />* These symptoms especially occur at the beginning of therapy. They are generally<br />mild and often disappear within 1 to 2 weeks.</p><p>&nbsp;</p><p>To reports any side effect(s):<br />&bull; Saudi Arabia<br />-The National Pharmacovigilance and Drug Safety Centre (NPC)<br />o Fax: +966-11-205-7662<br />o Call NPC at +966-11-2038222, Exts: 2317-2356-2340.<br />o Toll free phone: 19999<br />o E-mail: npc.drug@sfda.gov.sa<br />o Website: www.sfda.gov.sa/npc</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Symptoms<br />The most common signs expected with overdose of a beta-blocker are bradycardia, hypotension,<br />bronchospasm, acute cardiac insufficiency and hypoglycaemia. There is wide inter-individual<br />variation in sensitivity to one single high dose of bisoprolol and patients with heart failure are<br />probably very sensitive.<br />The clinical picture in acute or chronic overdose of hydrochlorothiazide ischaracterised by the<br />extent of fluid and electrolyte loss. The most common signs are dizziness, nausea, somnolence,<br />hypovolaemia, hypotension, hypokalaemia.<br />Management<br />In general, if overdose occurs, discontinuation of bisoprolol/hydrochlorothiazide and supportive<br />and symptomatic treatment is recommended.<br />Bradycardia: administer intravenous atropine. If the response is inadequate, isoprenaline or<br />another agent with positive chronotropic properties may be given cautiously. Under some<br />circumstances, transvenous pacemaker insertion may be necessary.<br />Hypotension: intravenous fluids and vasopressors should be administered. Atrioventricular block<br />(second or third degree): patients should be carefully monitored and treated with isoprenaline<br />infusion or intravenous cardiac pacemaker insertion.<br />Acute worsening of heart failure: administer intravenous diuretics, inotropic agents, vasodilating<br />agents.<br />Bronchospasm: administer bronchodilatator therapy such as isoprenaline, beta2-<br />sympatthomimetic agents and/or aminophylline.<br />Hypoglycaemia: administer intravenous glucose.<br />Limited data suggest that bisoprolol is hardly dialyzable. The degree to which<br />hydrochlorothiazide is removed by haemodialysis has not been established.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><br />Pharmacotherapeutic group: Beta blocking agents, selective<br />ATC Code: C07AB07G<br />Clinical studies have shown that the antihypertensive effects of these two drugs are additive, and<br />the efficacy of the lowest dose, 2.5 mg/12.5 mg, in the treatment of mild to moderate essential<br />hypertension has been demonstrated. The pharmacodynamic effects, including hypokalaemia<br />(hydrochlorothiazide), and bradycardia, asthenia and headache (bisoprolol fumarate) are doserelated.<br />Combining both active ingredients at one fourth/half the doses used in single agent<br />therapy (2.5 mg/12.5 mg) aims to reduce those effects.Bisoprolol fumarate is a highly selective<br />&beta;1-adrenoceptor blocking agent with no intrinsic sympathomimetic activity and without<br />significant membrane stabilizing activity.<br />As with other &beta;1-receptor blocking drugs, the mechanism of bisoprololfumarate&rsquo;s<br />antihypertensive effect has not been completely established.However, it has been shown that the<br />drug produces a marked decrease in plasma renin and a reduction in heart rate.<br />Hydrochlorothiazide is a thiazide diuretic with antihypertensive activity. Itsdiuretic effect is due<br />to inhibition of active Na+ transport from the renal tubules to the blood, affecting Na+ re<br />absorption. T e</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Bisoprolol<br />Absorption<br />Tmax varies from 1-4 hours.<br />Bioavailability is high (88%); hepatic extraction is very low; and absorption is not affected by<br />the presence of food. The kinetics are linear for doses from 5-40 mg.<br />Distribution<br />Plasma protein binding is 30%, and the volume of distribution is high (approximately 3 L/kg).<br />Biotransformation<br />40% of a bisoprolol dose is metabolised in the liver. Bisoprolol metabolites are inactive.&nbsp;</p><p>Elimination<br />The plasma elimination half-life is 11 hours.<br />Renal clearance and hepatic clearance are approximately comparable, and half of a dose<br />(unchanged) as well as the metabolites are excreted in urine. The total clearance is approximately<br />15 L/h.<br />Hydrochlorothiazide<br />Absorption<br />The bioavailability of hydrochlorothiazide shows between-subject variability and ranges from<br />60-80%. Tmax varies from 1.5-5 hours (mean value &asymp;4 hrs).<br />Distribution<br />Plasma protein binding is 40%.<br />Elimination<br />Hydrochlorothiazide is not metabolised and is excreted almost entirely as unchanged drug by<br />glomerular filtration and active tubular secretion. The terminal t&frac12; of hydrochlorothiazide is<br />approximately 8 hours.<br />The renal clearance of hydrochlorothiazide is reduced and the elimination half-life prolonged in<br />patients with renal and/or cardiac insufficiency. The same applies to elderly subjects, who also<br />show an increase in Cmax.<br />Hydrochlorothiazide crosses the placental barrier and is excreted in human milk</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Bisoprolol fumarate or hydrochlorothiazide have not been found to be hazardous to humans<br />according to the standard preclinical toxicity tests (longtermtoxicity, mutagenicity, genotoxicity<br />or carcinogenicity tests). Like otherbeta-blockers, bisoprolol fumarate at high doses has been<br />found in animal experiments to cause toxic effects to the mother (decreased food intake and body<br />weight gain), and to the embryo/foetus (increased late resorptions,reduced birth weight of the<br />offspring, retardation of the physical development up to the end of lactation). However,<br />bisoprolol fumarate as well as hydrochlorothiazide were not teratogenic. There was no increase<br />in toxicity when both components were given in combination</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>List of excipients<br />Maize starch<br />Microcrystalline Cellulose<br />Crospovidone<br />Dibasic Calcium Phosphate Dihydrate<br />Colloidal Silicone Dioxide<br />Magnesium Stearate<br />Purified Water<br />Opadry White<br />Propylene Glycol<br />Simethicone USP</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not Applicable&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2 years
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30 &deg;C</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Immediate Container: Alu-PVC/PVDC blister.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Jamjoom Pharmaceuticals Company.
P.O. Box 6267
Jeddah 21442
Tel: +966-12-6081111
Fax: +966-12-6081222.
Kingdom of Saudi Arabia
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Jan-2020
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>